Uzm. Dr. Mustafa Serkan Alemdar

• Neoplasms 3 publications
  Source: OpenAlex / PubMed MeSHView publications
• Rectal Neoplasms 2 publications

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: medicalpark.com.tr.

Experience

• ExperienceKonya Derebucak İlçe Hastanesi, 2006 - 2008medicalpark.com.tr
• ExperienceAkdeniz Üniversitesi Hastanesi, 2009 - 2015medicalpark.com.tr
• ExperienceAntalya Kaş Devlet Hastanesi, 2015 - 2015medicalpark.com.tr
• Experienceİnönü Üniversitesi Tıp Fakültesi, 2015 - 2016medicalpark.com.tr
• ExperienceAkdeniz Üniversitesi Hastanesi, 2016 - 2021medicalpark.com.tr
• ExperienceAntalya Eğitim ve Araştırma Hastanesi, 2021 - 2023medicalpark.com.tr

Education

• EducationKocaeli Üniversitesi Tıp Fakültesi, 2006medicalpark.com.tr
• EducationAkdeniz Üniversitesi Tıp Fakültesi, İç Hastalıkları, 2014medicalpark.com.tr
• EducationAkdeniz Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, 2018medicalpark.com.tr

• SpecialtyMedical Oncologymedicalpark.com.trFrom source
• Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
• InstitutionMedical Park Antalyamedicalpark.com.trFrom source
• Area of workNeoplasmsExtracted from 3 publications · Model version —From source
• Publications25 publicationsORCID, OpenAlex, Europe PMCFrom source
• ORCID0000-0002-7663-6182ORCIDFrom source
• Last synchronised4 November 2026 20:52https://www.medicalpark.com.tr/hekimler/mustafa-serkan-alemdarmedicalpark.com.tr

1. Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey

   Current Oncology, 2026

   DOI 10.3390/curroncol33040216 PMID 42041735 Open-access full textSource: ORCID

2. Causal Impact of Hemoglobin Levels on Global Quality of Life in Patients with Cancer

   Journal of Clinical Medicine, 2026

   DOI 10.3390/jcm15041579 PMID 41753266 Open-access full textSource: ORCID

3. Extent of Resection and Survival in IDH-Wildtype Glioblastoma: A Dual-Center Retrospective Study

   Medicina, 2026

   DOI 10.3390/medicina62020385 PMID 41752783 Open-access full textSource: ORCID

4. Real-world outcomes of trifluridine/tipiracil with or without bevacizumab in refractory metastatic colorectal cancer: a multicenter cohort study from Turkey

   Discover Oncology, 2026

   DOI 10.1007/s12672-026-05158-y PMID 42104040 Open-access full textSource: OpenAlex

5. Analysing Emotional Well-Being in Cancer Patients: A Natural Language Processing Approach to Correlating Text with Hospital Anxiety and Depression Scale Scores

   Current Oncology, 2026

   DOI 10.3390/curroncol33070400 PMID 42505202 Open-access full textSource: OpenAlex

6. The Use of Artificial Intelligence Chatbots by Newly Diagnosed Cancer Patients: A Descriptive Phenomenological Study

   Current Oncology, 2026

   DOI 10.3390/curroncol33090563 PMID 42782909 Open-access full textSource: OpenAlex

7. Association of neoadjuvant treatment-initiation season with pathological response and survival in locally advanced rectal cancer

   Journal of Health Sciences and Medicine, 2026

   DOI 10.32322/jhsm.1991234 Open-access full textSource: OpenAlex

8. The prognostic value of the Systemic Immune-Inflammation Index at diagnosis in small cell lung cancer

   Journal of Medicine and Palliative Care, 2026

   DOI 10.47582/jompac.1996340 Open-access full textSource: OpenAlex

9. Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach

   Cancers, 2025

   DOI 10.3390/cancers17020233 PMID 39858018 1 citation (Europe PMC) Open-access full textSource: Europe PMC

10. Predictive value of tumor marker index for pathological complete response following neoadjuvant chemoradiotherapy in locally advanced rectal cancer

    World Journal of Surgical Oncology, 2025

    DOI 10.1186/s12957-025-04081-w PMID 41327416 1 citation (OpenAlex) Open-access full textSource: OpenAlex